The emerging molecular genetics of sarcoma translocations

Diagnostic Molecular Pathology

Volumn 4, Issue 3, 1995, Pages 162-173

  Ladanyi, Marc ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chromosomal translocation; Ewing's; EWS; FlI1; Gene rearrangement; Liposarcoma; Molecular diagnosis; Reverse transcriptase polymerase chain reaction; Rhabdomyosarcoma; RNA binding protein; Sarcoma; Synovial sarcoma; Transcription factor; WT1

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 16; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 7; CLEAR CELL SARCOMA; EWING SARCOMA; GENE REARRANGEMENT; HUMAN; MYXOSARCOMA; NEUROECTODERM TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SYNOVIAL SARCOMA; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; HUMAN; MOLECULAR SEQUENCE DATA; SARCOMA; SUPPORT, NON-U.S. GOV'T; TRANSLOCATION (GENETICS);

EID: 0029087408     PISSN: 10529551     EISSN: 15334066     Source Type: Journal    
DOI: 10.1097/00019606-199509000-00003     Document Type: Article

References (95)

1. Aman P, Ron D. Mandahl N, Fioretos T, Heim S, Arheden K, Willen H, Rydholm A, Mitelman F. Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(ql3;pl 1). Genes Chromosom Cancer 1992;5: 278-85.
2. Aoki K, Nakahara K, Ikegawa C, Seto M. Takahashi T, Minowada J, Strominger JL, Maziarz RT, Kasai M. Nuclear proteins binding to a novel target sequence within the recombination hotspot regions of Bcl-2 and the immunoglobulin DH gene family. Oncogene 1994;9:1109-15.
3. Amheim N. The possible role of Z DNA in chromosomal translocations. Cancer Cells 1990;2:121-2.
4. Aurias A, Rimbaut C, Buffe D, et al. Translocation involving chromosome 22 in Ewing's sarcoma: A cytogenetic study of four fresh tumors. Cancer Genet Cytogenet 1984;12:21-9.
5. Bailly RA, Bosselut R. Zucman J, Cormier F, Delattre O, Roussel M, Thomas G, Ghysdael J. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol 1994;14:3230-41.
6. Bames WM. PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates. Proc Natl Acad Sci USA 1994;91:2216-20.
7. Barone MV, Crozat A, Tabaee A, Philipson L, Ron D. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of Gl/S arrest. Genes Dev 1994;8:453-64.
8. Bickmore WA, Oghene K, Little MH, Seawright A, van Heyningen V, Hastie ND. Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wtl gene transcript. Science 1992;257:235-7.
9. Biegel JA, Conard K, Brooks JJ. Translocation (11;22)(pl3;ql2): primary change in intra-abdominal desmoplastic small round cell tumor. Genes Chromosom Cancer 1993;7: 119-21.
10. Bouffler S, Silver A, Cox R. The role of DNA repeats and associated secondary structures in genomic instability and neoplasia. Bioessays 1993;15:409-12.
11. Burd CG, Dreyfuss G. Conserved structures and diversity of functions of RNA-binding proteins. Science 1994;265:615-21.
12. Cheng S, Chang SY, Gravitt P, Respess R. Long PCR. Nature 1994;369:684-5.
13. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AML, Gusterson BA, Cooper CS. Identification of novel genes, SYT and SSX, involved in t(X;18)(pl 1.2;ql 1.2) translocation found in human synovial sarcoma. Nat Genet 1994;7: 502-8.
14. Cleary ML. Oncogenic conversion of transcription factors by chromosomal translocations. Cell 1991;66:619-22.
15. Coppes MJ, Haber DA, Grundy PE. Genetic events in the development of Wilms’ tumor. N Engl J Med 1994;331:586- 90.
16. Crozat A, Aman P, Mandahl N, Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993;363:640-4.
17. Davis RJ, D’Cruz CM, Lovell MA, Biegel JA, Barr FG. Fusion of PAX7 to FKHR by the variant t(l;13)(p36;q!4) translocation in alveolar rhabdomyosarcoma. Cancer Res 1994;54:2869-72.
18. Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, Aurias A, Thomas G. The Ewing family of tumors—a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994;331:294-9.
19. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M. Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A, Thomas G. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992;359:162-5.
20. De Leeuw B, Suijkerbuijk RF. Olde Weghuis D, Meloni AM, Stenman G, Kindblom LG, Balemans M, van den Berg E, Molenaar WM, Sandberg AA, Geurts van Kessel A. Distinct Xpll.2 breakpoint regions in synovial sarcoma revealed by metaphase and interphase FISH: relationship to histologic subtypes. Cancer Genet Cytogenet 1994;73:89-94.
21. Desmaze C, Zucman J, Delattre O, Melot T, Thomas G, Aurias A. Interphase molecular cytogenetics of Ewing’s sarcoma and peripheral neuroepithelioma t(11;22) with flanking and overlapping cosmid probes. Cancer Genet Cytogenet 1994;74:13-8.
22. Desmaze C, Zucman J, Delattre O, Thomas G, Aurias A. Unicolor and bicolor in situ hybridization in the diagnosis of peripheral neuroepithelioma and related tumors. Genes Chromosom Cancer 1992;5:30-4.
23. Downing JR, Khandekar A, Shurtleff SA, Head DR, Parham DM, Webber BL, Pappo AS, Hulshof MG, Conn WP, Shapiro DN. Multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing’s sarcoma. Am J Pathol 1995;146:626-34.
24. Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ. Repression of the insulin-like growth factor II gene by the wilms tumor suppressor wtl. Science 1992;257:674-8.
25. Dunn T, Praissman L, Hagag N, Viola MV. ERG gene is translocated in an Ewing's sarcoma cell line. Cancer Genet Cytogenet 1994;76:19-22.
26. Finger LR, Harvey RC, Moore RC, Showe LC, Croce CM. A common mechanism of chromosomal translocation in T- and B-cell neoplasia. Science 1986;234:982-5.
27. Forster A, Thompson S, Lampert F, Kaneko Y, Slater R, Kroes WG, van der Schoot CE, Ludwig WD, Karpas A, Pocock C, Cotter F, Rabbits TH. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc Natl Acad Sci USA 1993;90:8538-42.
28. Galili N, Davis RJ, Fredericks WJ, Mukhopadhyay S, Rauscher 111 FJ, Emanuel BJ, Rovera G, Barr FG. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhadomyosarcoma. Nat Genet 1993;5:230-5.
29. Gashler AL, Bonthron DT, Madden SL, Rauscher FJ, Collins T, Sukhatme VP. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WTL Proc Nat Acad Sci USA 1992;89:10984-8.
30. Gerald WL. The molecular genetics of Wilms’ tumor: A paradigm of heterogeneity in tumor development. Cancer Invest 1994;12:350-9.
31. Gerald WL, Miller HK, Battifora H, Miettinen M, Silva EG, Rosai J. Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am J Surg Pathol 1991;15:499-513.
32. Gerald WL, Rosai J, Ladanyi M. Characterization of the genomic breakpoint and chimeric transcripts in the EWS- WT1 gene fusion of desmoplastic small round cell tumor. Proc Nat Acad Sci USA 1995;92:1028-32.
33. Giovannini M, Biegel JA, Serra M, Wang JY, Wei YH, Ny- cum L, Emanuel BS, Evans GA. EWS-erg and EWS-Flil fusion transcripts in Ewing’s sarcoma and primitive neuroectodermal tumors with variant translocations. J Clin Invest 1994;94:489-96.
34. Giovannini M, Selleri L, Biegel JA, Scotlandi K, Emanuel BS, Evans GA. Interphase cytogenetics for the detection of the t(11;22)(q24;q 12) in small round cell tumors. J Clin Invest 1992;90:1911-8.
35. Gu Y, Alder H, Nakamura T, Schichman SA, Prasad R, Canaani O, Saito H, Croce CM, Canaani E. Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia. Cancer Res 1994;54:2326-30.
36. Haber DA, Park S, Maheswaran S, Englert C, Re GG, Ha- zen-Martin DJ, Sens DA, Garvin AJ. WTl-mediated growth suppression of Wilms tumor cells expressing a WTI splicing variant. Science 1993;262:2057-9.
37. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE. Alternative splicing and genomic structure of the Wilms tumor gene WTI. Proc Natl Acad Sci USA 1991; 88:9618-22.
38. Hai T, Liu F, Coukos WJ, Green MR. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding hetero- dimers. Genes Dev 1989;3:2083-90.
39. Harrington MA, Konicek B, Song A, Xia XL, Fredericks WJ, Rauscher FJ. Inhibition of colony-stimulating factor-I promoter activity by the product of the Wilms tumor locus. J BiolChem 1993;268:21271-5.
40. Hromas R, May W, Denny C, Raskind W. Moore J, Maki RA, Beck E, Klemsz MJ. Human FLI-I localizes to chromosome 11Q24 and has an aberrant transcript in neuroepithelioma. Biochim Biophys Acta 1993;1172:155-8.
41. Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welbom JL, Willman CL, Cleary ML. HRX involvement in de novo and secondary leukemias with diverse chromosome Uq23 abnormalities. Blood 1993;81:3197-203.
42. Ichikawa H. Shimizu K, Hayashi Y, Ohki M. An RNA- binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res 1994;54:2865-8.
43. Jaeger U, Purtscher B, Karth GD, Knapp S, Mannhalter C, Lechner K. Mechanism of the chromosomal translocation t(14; 18) in lymphoma: detection of a 45-Kd breakpoint binding protein. Blood 1993;81:1833-40.
44. Jeon I-S, Davis JN, Braun BS, Sublett JE, Roussel MF. Denny CT, Shapiro DN. A variant Ewing’s sarcoma translocation t(7;22) fuses the EWS gene to the ETS gene ETVI. Oncogene 1995;10:1229-34.
45. Klemsz MJ, Maki RA, Papayannopoulou T, Moore J, Hromas R. Characterization of the ets oncogene family member. fli-1. J Biol Chem 1993;268:5769-73.
46. Knapp S, Delle Karth G, Friedl J, Purtscher B, Mitterbauer G, Domer PH, Jaeger U. Guanine-rich (GGNNGG) elements at chromosomal breakpoints interact with a loopforming, single-stranded DNA-binding protein. Oncogene 1994;9:1501-5.
47. Knight JC, Renwick PJ, Dal Cin P, Van den Berghe H, Fletcher CDM. Translocation t(12; 16)(q 13;pl 1) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res 1995;55:24-7.
48. Krowczynska AM, Rudders RA, Krontiris TG. The human minisatellite consensus at breakpoints of oncogene translocations. Nucleic Acids Res 1990;18:1121-7.
49. Ladanyi M, Gerald W. Fusion of the EWS and WTI genes in the desmoplastic small round cell tumor. Cancer Res 1994; 54:2837-40.
50. Ladanyi M, Lewis R, Garin-Chesa P, Rettig WJ, Huvos AG, Healey JH, Jhanwar SC, EWS rearrangement in Ewing s sarcoma and peripheral neuroectodermal tumor. Molecular detection and correlation with cytogenetic analysis and MIC2 expression. Diagn Mol Pathol 1993;2:141-6.
51. Lee W, Han K, Harris CP, Shim S, Kim S Meisner LF. Use of FISH to detect chromosomal translocations and deletions. Analysis of chromosome rearrangement in synovial sarcoma cells from paraffin-embedded specimens. Am J Pathol 1993;143:15-9.
52. Lessnick SL, Braun BS, Denny CT, May WA. Multiple domains mediate transformation by the Ewing s sarcoma EWS/FLI-I fusion gene. Oncogene 1995;10:423-31.
53. Mao X, Miesfeldt S, Yang H, Leiden JM, Thompson CB. The FLI-1 and chimeric EWS-FLI-I oncoproteins display similar DNA binding specificities. J Biol Chem 1994;269: 18216-22.
54. May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BC, Delattre O, Zucman J, Thomas G, Denny CT. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLU for transformation. Proc Natl Acad Sci USA 1993; 90:5752-6.
55. May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, Hromas R, Denny CT. The Ewing’s sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 Mol Cell Biol 1993;13:7393-8.
56. McKeon C, Thiele CJ, Ross RA, et al. Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma. Cancer Res 1988,48:4307.
57. Meyer D, Wolff CM, Stiegler P, Senan F, Befort N, Befort JJ, Remy P. Xl-fli, the Xenopus homologue of the fli-1 gene, is expressed during embryogenesis in a restricted pattern evocative of neural crest derivation. Mech Dev 1993;44:109-21.
58. Mrozek K, Karakousis CP, Bloomfield CD. Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12ql5 and in myxoid liposarcoma to 12q 13.3 Cancer Res 1993;53:1670-5.
59. Nilbert M, Mandahl N, Aman P, Rydholm A, Mitelman F. No rearrangements of the CHOP gene in malignant fibrous histiocytoma. Cancer Genet Cytogenet 1994;72:155-6.
60. Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN, Reddy ESP. The EWS gene, involved in Ewing family tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene 1994;9:3087-97.
61. Ohno T, Rao VN, Reddy ES. EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res 1993;53:5859l-63.
62. Panagopoulos I. Mandahl N. Ron D, Hoglund M, Nilbert M, Mertens F Mitelman F, Aman P. Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposar- comas with the 12;16 translocation. Cancer Res 1994;54: 6500-3.
63. Parham DM, Shapiro DN, Downing JR. Webber BL, Douglass EC. Solid alveolar rhabdomyosarcomas with the t(2;13). Report of two cases with diagnostic implications. Am J Surg Pathol 1994;18:474-8.
64. Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D, Fletcher J, Shipman R, Rheinwald J, Dem- etri G, et al. The Wilms tumour gene WTI is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nat Genet 1993;4:415-20.
65. Park S, Tomlinson G, Nisen P, Haber DA. Altered transact vational properties of a mutated WTI gene product in a WAGR-associated Wilms’ tumor. Cancer Res 1993;53:4757-60.
66. Park VM, Gustashaw KM, Wathen TM. The presence of interstitial telomeric sequences in constitutional chromosome abnormalities. Am J Hum Genet 1992;50:914-23.
67. Plougastel B, Zucman J, Peter M, Thomas G, Delattre 0. Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation. Genomics 1993;18:609-15.
68. Prasad DD, Rao VN, Reddy ES. Structure and expression of human fli-1 gene. Cancer Res 1992;52:5833-7.
69. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D. Gosden C, Bard J, Buckler A, Pelletier J, Hous- man D, van Heyningen V, Hastie N. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 1990;346:194-7.
70. Babbitts TH, Forster A, Larson R, Nathan P. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12; 16) in malignant li- posarcoma. Nat Genet 1993;4:175-80.
71. Rauscher FJ. The WT1 Wilms tumor gene product; a devel- opmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J 1993;7:896-903.
72. Rodriguez E. Sreekantaiah C, Gerald W, Reuter VE, Motzer RJ, Chaganti RSK. A recurring translocation. t(ll;22)- (pl3;qll.2), characterizes intra-abdominal desmoplastic small round-cell tumors. Cancer Genet Cvtogenet 1993;69: 17-21.
73. Ron D, Brasier AR. McGehee RE Jr. Habener JF. Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCAAT/enhancer binding protein (C/EBP). J Clin Invest 1992;89: 223-33.
74. Ron D. Habener JF CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant negative inhibitor of gene transcription. Genes Dev 1992;6:439-53.
75. Sanchez-Garcia I, Rabbitts TH. Transcriptional activation by TALI and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. Proc Natl Acad Sci USA 1994;91:7869-73.
76. Sandberg AA. Bridge JA. The cytogenetics of bone and soft tissue tumors. R.G. Landes Co., 1994.
77. Sawyer JR, Tryka AF, Lewis JM. A novel reciprocal chromosome translocation t(l I;22)(pl3;ql2) in an intraabdominal desmoplastic small round-cell tumor. Am J Surg Pathol 1992;16:411-6.
78. Shapiro D, Sublett JE, Li B, Downing JR, Naeve CW. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhadomyosarcoma. Cancer Res 1993;53:5108-12.
79. Shipley JM, Clark J, Crew AJ, Birdsall S, Rocques PJ, Gill S, Chelly J, Monaco AP, Abe S, Gusterson BA, Cooper CS. The t(X;18)(pll.2;qll.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome. Oncogene 1994;9:1447-53.
80. Sorensen PHB, Lessnick SL, Lopez-Terrada D, Liu XF Triche TJ, Denny CT. A second Ewing’s sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 1994;6:146-51.
81. Sorensen PHB, Liu XF, Delattre O, Rowland JM, Biggs CA, Thomas G, Triche T. Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood. Diagn Mol Pathol 1993;2:147-57.
82. Sorensen PHB, Shimada H, Liu XF Lim JF, Thomas G, Triche TJ. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing’s sarcoma EWS/FLI1 fusion gene. Cancer Res 1995;55:1385-92.
83. Sreekantaiah C, Ladanyi M, Rodriguez E Chaganti RSK. Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol 1994;144:1121-34.
84. Stenman G, Sahlin P, Mark J, Chaganti RSK, Kindblom LG, Aman P. The 12q 13-q 15 translocation breakpoints in pleomorphic adenoma and clear-cell sarcoma of tendons and aponeuroses are different from that in myxoid liposarcoma. Genes Chromosom Cancer 1993;7:178-80.
85. Taylor C, Patel K, Jones T, Kiely F, De Stavola BL, Sheer D. Diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumour based on the detection of (11,22)using fluorescence in situ hybridisation. Br I Cancer 1993;67:128-33.
86. Toth G, Jurka J. Repetitive DNA in and around translocation breakpoints of the Philadelphia chromosome. Gene 1994;140:285-8.
87. Turc-Carel C, Aurias A, Mugneret F Lizard S, Sidaner I, Volk C, Thiery JP, Olschwang S, Philip I, Berger MP, Philip T. Lenoir GM, Mazabraud A. Chromosomes in Ewing’s sarcoma. 1. An evaluation of 85 cases and remarkable consistency of t(II;22)(q24;q 12). Cancer Genet Cytogenet 1988;32: 229-38.
88. Turc-Carel C, Philip I, Berger M-P, Philip T, Lenoir GM. Chromosome study of Ewing s sarcoma (ES) cell lines. Consistency of a reciprocal translocation t(11;22)(q24;q 12). Cancer Genet Cytogenet 1984;12:1-19.
89. Watson DK, Smyth FE, Thompson DM, Cheng JQ, Testa JR, Papas TS, Seth A. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. Cell Growth Differ 1992;3:705-13.
90. Wyatt RT, Rudders RA, Zelenetz A, DeLeilis RA, Krontiris TG. Be 12 oncogene translocation is mediated by a chi-like consensus. J Exp Med 1992;175:1575-88.
91. Zhang L, Lemarchandel V, Romeo PH, Ben-David Y, Greer P, Bernstein A. The Fli-1 proto-oncogene, involved in eryth- roleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members. Oncogene 1993;8:1621-30.
92. Zinszner H, Albalat R, Ron D. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev 1994;8: 2513-26.
93. Zucman J, Delattre O, Desmaze C, Epstein A, Stenman G, Speleman F, Fletchers CDM, Aurias A, Thomas G. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 1993;4:341-5.
94. Zucman J. Delattre O, Desmaze C, Plougastel B, Joubert I, Melot T, Peter M, De Jong P, Rouleau G, Aurias A, Thomas G. Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints. Genes Chromosom Cancer 1992;5:271-7.
95. Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C, Ambros P, Combaret V, Lenoir G, Aurias A, Thomas G, Delattre O. Combinatorial generation of variable fusion proteins in the Ewing family of tumors. EMBO J 1993; 12: 4481-7.